Real-world event-free survival with neoadjuvant pembrolizumab plus chemotherapy and adjuvant pembrolizumab in early-stage triple-negative and estrogen receptor-low, HER2-negative breast cancer
Yosuke Aoyama, Yukinori Ozaki, Masahiro Kuno, Jun Masuda, Meiko Nishimura, Mami Kurata et al. Real-world event-free survival with neoadjuvant pembrolizumab plus chemotherapy and adjuvant pembrolizumab in early-stage triple-negative and estrogen receptor-low, HER2-negative breast cancer. // BMC Cancer. – 2026. – DOI: 10.1186/s12885-026-17065-0. – URL: https://doi.org/10.1186/s12885-026-17065-0
Yosuke Aoyama, Yukinori Ozaki, Masahiro Kuno, Jun Masuda, Meiko Nishimura, Mami Kurata, Lina Inagaki, Mari Hosonaga, Ippei Fukada, Emi Taniguchi, Yuri Kimura, Tetsuyo Maeda, Kazuyo Yoshida, Nami Yamashita, Takayuki Kobayashi, Toshimi Takano, & Takayuki Ueno (2026). Real-world event-free survival with neoadjuvant pembrolizumab plus chemotherapy and adjuvant pembrolizumab in early-stage triple-negative and estrogen receptor-low, HER2-negative breast cancer. BMC Cancer. https://doi.org/10.1186/s12885-026-17065-0
Yosuke Aoyama, et al. “Real-world event-free survival with neoadjuvant pembrolizumab plus chemotherapy and adjuvant pembrolizumab in early-stage triple-negative and estrogen receptor-low, HER2-negative breast cancer.” BMC Cancer, 2026. doi:10.1186/s12885-026-17065-0.
@article{Aoyama2026,
title = {Real-world event-free survival with neoadjuvant pembrolizumab plus chemotherapy and adjuvant pembrolizumab in early-stage triple-negative and estrogen receptor-low, HER2-negative breast cancer},
author = {Aoyama, Yosuke and Ozaki, Yukinori and Kuno, Masahiro and Masuda, Jun and Nishimura, Meiko and Kurata, Mami and Inagaki, Lina and Hosonaga, Mari and Fukada, Ippei and Taniguchi, Emi and Kimura, Yuri and Maeda, Tetsuyo and Yoshida, Kazuyo and Yamashita, Nami and Kobayashi, Takayuki and Takano, Toshimi and Ueno, Takayuki},
journal = {BMC Cancer},
year = {2026},
doi = {10.1186/s12885-026-17065-0},
url = {https://doi.org/10.1186/s12885-026-17065-0}
}